SMTL ID : 3thb.1 (1 other biounit)

Structure of PLK1 kinase domain in complex with a benzolactam-derived inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 2 residues within 4Å: Chain A: H.81, C.200 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:H.81, A:C.200

1 x 3TA: 9-chloro-2-({5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl}amino)-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepine-6-thi one(Non-covalent)

3TA.2: 18 residues within 4Å: Chain A: L.47, G.48, K.49, G.50, C.55, A.68, K.70, V.102, E.119, L.120, C.121, R.124, S.125, E.128, G.168, F.171, G.181, D.182 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.47, A:L.47, A:A.68, A:L.120, A:R.124, A:F.171 Hydrogen bonds: A:C.121, A:C.121, A:D.182 Salt bridges: A:E.128

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Duffey, M.O. et al., Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905). J.Med.Chem. (2012)

Release Date

2011-11-23

Peptides

Serine/threonine-protein kinase PLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PLK1

Related Entries With Identical Sequence